Validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system

Yulia V Kotovskaya,1 Zhanna D Kobalava,1 Artemy V Orlov21Propedeutics Department, Peoples’ Friendship University of Russia, 2Competitive System Analysis Department (No 65), National Research Nuclear University MEPhI, Moscow, RussiaBackground: The objective of this study was to validate th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kotovskaya YV, Kobalava ZD, Orlov AV
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/39291e55f882492a85e5f0baa2564774
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:39291e55f882492a85e5f0baa2564774
record_format dspace
spelling oai:doaj.org-article:39291e55f882492a85e5f0baa25647742021-12-02T02:41:26ZValidation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system1179-1470https://doaj.org/article/39291e55f882492a85e5f0baa25647742014-05-01T00:00:00Zhttp://www.dovepress.com/validation-of-the-integration-of-technology-that-measures-additional-l-a16646https://doaj.org/toc/1179-1470 Yulia V Kotovskaya,1 Zhanna D Kobalava,1 Artemy V Orlov21Propedeutics Department, Peoples’ Friendship University of Russia, 2Competitive System Analysis Department (No 65), National Research Nuclear University MEPhI, Moscow, RussiaBackground: The objective of this study was to validate the novel integration of oscillometric (Vasotens®) technology into a BPLab® ambulatory blood pressure (BP) monitoring system to measure central BP, the aortic augmentation index, and pulse wave velocity (PWV) compared with the recommended and widely accepted tonometric method.Methods: The ARTERY Society guidelines for comparison of PWV measurement techniques were used as the basis for recruitment of 99 individuals (mean age 44±19 years, 52 males). The standard for comparison was the conventional “classic” SphygmoCor device.Results: Accordance of the two methods was satisfactory (r=0.98, mean difference of 2.9±3.5 mmHg for central systolic BP; r=0.98, mean difference of −1.1±2.3 mmHg for central diastolic BP; r=0.83, mean difference of −2.6%±13% for aortic augmentation index; r=0.85, mean difference of 0.69±1.4 for PWV).Conclusion: The performance of Vasotens algorithms using an oscillometric ambulatory BP monitoring system is feasible for accurate diagnosis, risk assessment, and evaluation of the effects of antihypertensive drugs.Keywords: validation study, ambulatory, 24-hour, monitoring, arterial stiffness, pulse wave velocity, augmentation index, central blood pressureKotovskaya YVKobalava ZDOrlov AVDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2014, Iss default, Pp 91-97 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medical technology
R855-855.5
spellingShingle Medical technology
R855-855.5
Kotovskaya YV
Kobalava ZD
Orlov AV
Validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system
description Yulia V Kotovskaya,1 Zhanna D Kobalava,1 Artemy V Orlov21Propedeutics Department, Peoples’ Friendship University of Russia, 2Competitive System Analysis Department (No 65), National Research Nuclear University MEPhI, Moscow, RussiaBackground: The objective of this study was to validate the novel integration of oscillometric (Vasotens®) technology into a BPLab® ambulatory blood pressure (BP) monitoring system to measure central BP, the aortic augmentation index, and pulse wave velocity (PWV) compared with the recommended and widely accepted tonometric method.Methods: The ARTERY Society guidelines for comparison of PWV measurement techniques were used as the basis for recruitment of 99 individuals (mean age 44±19 years, 52 males). The standard for comparison was the conventional “classic” SphygmoCor device.Results: Accordance of the two methods was satisfactory (r=0.98, mean difference of 2.9±3.5 mmHg for central systolic BP; r=0.98, mean difference of −1.1±2.3 mmHg for central diastolic BP; r=0.83, mean difference of −2.6%±13% for aortic augmentation index; r=0.85, mean difference of 0.69±1.4 for PWV).Conclusion: The performance of Vasotens algorithms using an oscillometric ambulatory BP monitoring system is feasible for accurate diagnosis, risk assessment, and evaluation of the effects of antihypertensive drugs.Keywords: validation study, ambulatory, 24-hour, monitoring, arterial stiffness, pulse wave velocity, augmentation index, central blood pressure
format article
author Kotovskaya YV
Kobalava ZD
Orlov AV
author_facet Kotovskaya YV
Kobalava ZD
Orlov AV
author_sort Kotovskaya YV
title Validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system
title_short Validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system
title_full Validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system
title_fullStr Validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system
title_full_unstemmed Validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system
title_sort validation of the integration of technology that measures additional “vascular” indices into an ambulatory blood pressure monitoring system
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/39291e55f882492a85e5f0baa2564774
work_keys_str_mv AT kotovskayayv validationoftheintegrationoftechnologythatmeasuresadditionalldquovascularrdquoindicesintoanambulatorybloodpressuremonitoringsystem
AT kobalavazd validationoftheintegrationoftechnologythatmeasuresadditionalldquovascularrdquoindicesintoanambulatorybloodpressuremonitoringsystem
AT orlovav validationoftheintegrationoftechnologythatmeasuresadditionalldquovascularrdquoindicesintoanambulatorybloodpressuremonitoringsystem
_version_ 1718402277418467328